Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.98960293 |
2 | vocalization behavior (GO:0071625) | 5.19899663 |
3 | synaptic vesicle exocytosis (GO:0016079) | 5.07464894 |
4 | neuron cell-cell adhesion (GO:0007158) | 4.97881397 |
5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.89202683 |
6 | synaptic vesicle maturation (GO:0016188) | 4.85348697 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.83987877 |
8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81261414 |
9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.76505995 |
10 | presynaptic membrane assembly (GO:0097105) | 4.72224188 |
11 | presynaptic membrane organization (GO:0097090) | 4.68386220 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.60609859 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.60448707 |
14 | locomotory exploration behavior (GO:0035641) | 4.59382397 |
15 | glutamate secretion (GO:0014047) | 4.55931015 |
16 | protein localization to synapse (GO:0035418) | 4.51848445 |
17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.51673800 |
18 | regulation of synaptic vesicle transport (GO:1902803) | 4.30009612 |
19 | neurotransmitter secretion (GO:0007269) | 4.27774054 |
20 | neuronal action potential propagation (GO:0019227) | 4.07094677 |
21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.05971570 |
22 | synaptic transmission, glutamatergic (GO:0035249) | 4.04794056 |
23 | glutamate receptor signaling pathway (GO:0007215) | 4.03701687 |
24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.02089393 |
25 | neuron-neuron synaptic transmission (GO:0007270) | 3.97584676 |
26 | regulation of T cell tolerance induction (GO:0002664) | 3.93567706 |
27 | imidazole-containing compound metabolic process (GO:0052803) | 3.91440371 |
28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91281751 |
29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.89408102 |
30 | exploration behavior (GO:0035640) | 3.88221784 |
31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.83839331 |
32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.82250502 |
33 | positive regulation of mast cell degranulation (GO:0043306) | 3.79497318 |
34 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.79497318 |
35 | neuron recognition (GO:0008038) | 3.78298914 |
36 | layer formation in cerebral cortex (GO:0021819) | 3.75881959 |
37 | proline transport (GO:0015824) | 3.75198428 |
38 | postsynaptic membrane organization (GO:0001941) | 3.74524940 |
39 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.73778676 |
40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.72073799 |
41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68323622 |
42 | gamma-aminobutyric acid transport (GO:0015812) | 3.64492956 |
43 | positive regulation of mast cell activation (GO:0033005) | 3.60244009 |
44 | regulation of tolerance induction (GO:0002643) | 3.59275372 |
45 | neurotransmitter transport (GO:0006836) | 3.58480416 |
46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.55268176 |
47 | regulation of synapse structural plasticity (GO:0051823) | 3.49931644 |
48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.47062749 |
49 | long-term memory (GO:0007616) | 3.43113509 |
50 | response to histamine (GO:0034776) | 3.39143247 |
51 | dendritic spine morphogenesis (GO:0060997) | 3.37521625 |
52 | synaptic vesicle endocytosis (GO:0048488) | 3.37444830 |
53 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.37208008 |
54 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.36998456 |
55 | positive regulation of membrane potential (GO:0045838) | 3.36739980 |
56 | activation of protein kinase A activity (GO:0034199) | 3.33077698 |
57 | positive regulation of synapse assembly (GO:0051965) | 3.30170550 |
58 | transmission of nerve impulse (GO:0019226) | 3.28235439 |
59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.26751639 |
60 | regulation of neurotransmitter levels (GO:0001505) | 3.26314480 |
61 | catechol-containing compound biosynthetic process (GO:0009713) | 3.25696339 |
62 | catecholamine biosynthetic process (GO:0042423) | 3.25696339 |
63 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.24719788 |
64 | axonal fasciculation (GO:0007413) | 3.22693910 |
65 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.20212903 |
66 | regulation of neurotransmitter secretion (GO:0046928) | 3.19563734 |
67 | long-term synaptic potentiation (GO:0060291) | 3.19334318 |
68 | startle response (GO:0001964) | 3.17283242 |
69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15819779 |
70 | synapse assembly (GO:0007416) | 3.13827473 |
71 | macroautophagy (GO:0016236) | 3.11825675 |
72 | regulation of vesicle fusion (GO:0031338) | 3.11518706 |
73 | positive regulation of regulated secretory pathway (GO:1903307) | 3.10154614 |
74 | detection of calcium ion (GO:0005513) | 3.09959680 |
75 | membrane depolarization during action potential (GO:0086010) | 3.09222506 |
76 | positive regulation of leukocyte degranulation (GO:0043302) | 3.07538960 |
77 | membrane hyperpolarization (GO:0060081) | 3.06825176 |
78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.06212129 |
79 | membrane depolarization (GO:0051899) | 3.04753454 |
80 | cellular potassium ion homeostasis (GO:0030007) | 3.04166077 |
81 | regulation of synaptic plasticity (GO:0048167) | 3.03995775 |
82 | auditory behavior (GO:0031223) | 2.98827556 |
83 | behavioral defense response (GO:0002209) | 2.98667564 |
84 | behavioral fear response (GO:0001662) | 2.98667564 |
85 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.98344870 |
86 | regulation of neurotransmitter transport (GO:0051588) | 2.98108681 |
87 | neuromuscular process controlling posture (GO:0050884) | 2.98011050 |
88 | negative regulation of cell killing (GO:0031342) | 2.97105304 |
89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97105304 |
90 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.97025777 |
91 | innervation (GO:0060384) | 2.96200176 |
92 | response to auditory stimulus (GO:0010996) | 2.95037606 |
93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94405967 |
94 | positive regulation of synapse maturation (GO:0090129) | 2.92949365 |
95 | synaptic transmission (GO:0007268) | 2.91278384 |
96 | vesicle transport along microtubule (GO:0047496) | 2.90806251 |
97 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90690403 |
98 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.90335914 |
99 | learning (GO:0007612) | 2.90119780 |
100 | fear response (GO:0042596) | 2.89462320 |
101 | regulation of beta-amyloid formation (GO:1902003) | 2.89095727 |
102 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87697174 |
103 | striatum development (GO:0021756) | 2.85874267 |
104 | dendrite morphogenesis (GO:0048813) | 2.85644626 |
105 | positive regulation of synaptic transmission (GO:0050806) | 2.85131598 |
106 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.84621911 |
107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.84324548 |
108 | mechanosensory behavior (GO:0007638) | 2.84158423 |
109 | regulation of synapse assembly (GO:0051963) | 2.83788902 |
110 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83580172 |
111 | regulation of respiratory system process (GO:0044065) | 2.81772579 |
112 | synaptic vesicle transport (GO:0048489) | 2.81729838 |
113 | establishment of synaptic vesicle localization (GO:0097480) | 2.81729838 |
114 | social behavior (GO:0035176) | 2.81173114 |
115 | intraspecies interaction between organisms (GO:0051703) | 2.81173114 |
116 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.80403199 |
117 | calcium ion-dependent exocytosis (GO:0017156) | 2.80317498 |
118 | mating behavior (GO:0007617) | 2.78519629 |
119 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.67338436 |
120 | regulation of mast cell activation (GO:0033003) | 2.64317535 |
121 | regulation of T cell cytokine production (GO:0002724) | 2.62552390 |
122 | detection of molecule of bacterial origin (GO:0032490) | 2.60380248 |
123 | peptide hormone processing (GO:0016486) | 2.57011649 |
124 | positive regulation of exocytosis (GO:0045921) | 2.56069835 |
125 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.54122277 |
126 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.53166153 |
127 | regulation of regulated secretory pathway (GO:1903305) | 2.52775655 |
128 | regulation of mast cell degranulation (GO:0043304) | 2.52581090 |
129 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.46665188 |
130 | positive regulation of glycolytic process (GO:0045821) | 2.45067414 |
131 | cellular extravasation (GO:0045123) | 2.44025864 |
132 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.43757729 |
133 | cellular response to epinephrine stimulus (GO:0071872) | 2.43719497 |
134 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.38337101 |
135 | negative regulation of protein oligomerization (GO:0032460) | 2.36155152 |
136 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.36141718 |
137 | cellular response to monoamine stimulus (GO:0071868) | 2.35664525 |
138 | cellular response to catecholamine stimulus (GO:0071870) | 2.35664525 |
139 | relaxation of cardiac muscle (GO:0055119) | 2.35551824 |
140 | response to monoamine (GO:0071867) | 2.35292953 |
141 | response to catecholamine (GO:0071869) | 2.35292953 |
142 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.34055476 |
143 | regulation of leukocyte degranulation (GO:0043300) | 2.32718953 |
144 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.30407135 |
145 | positive regulation of Rap GTPase activity (GO:0032854) | 2.29365527 |
146 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.27783772 |
147 | regulation of ARF protein signal transduction (GO:0032012) | 2.26182864 |
148 | angiotensin maturation (GO:0002003) | 2.24290156 |
149 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.24090678 |
150 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.23194896 |
151 | regulation of exocytosis (GO:0017157) | 2.22763347 |
152 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.21999386 |
153 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.21999386 |
154 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.20021056 |
155 | negative regulation of B cell mediated immunity (GO:0002713) | 2.18210869 |
156 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.18210869 |
157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.17416269 |
158 | regulation of glucokinase activity (GO:0033131) | 2.17026763 |
159 | regulation of hexokinase activity (GO:1903299) | 2.17026763 |
160 | protein targeting to Golgi (GO:0000042) | 2.16965433 |
161 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.16164196 |
162 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.15447982 |
163 | nerve growth factor signaling pathway (GO:0038180) | 2.15440261 |
164 | insulin secretion (GO:0030073) | 2.13670859 |
165 | response to epinephrine (GO:0071871) | 2.11869797 |
166 | neutrophil mediated immunity (GO:0002446) | 2.11809410 |
167 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.10918319 |
168 | establishment of protein localization to Golgi (GO:0072600) | 2.10072237 |
169 | cerebellar granule cell differentiation (GO:0021707) | 2.09960201 |
170 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.09523337 |
171 | urinary tract smooth muscle contraction (GO:0014848) | 2.09509362 |
172 | activated T cell proliferation (GO:0050798) | 2.08987303 |
173 | response to parathyroid hormone (GO:0071107) | 2.07064825 |
174 | chemosensory behavior (GO:0007635) | 2.05942632 |
175 | regulation of Rap GTPase activity (GO:0032317) | 2.05452610 |
176 | microglial cell activation (GO:0001774) | 2.05346378 |
177 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.05292327 |
178 | macrophage activation involved in immune response (GO:0002281) | 2.01419737 |
179 | cellular response to ethanol (GO:0071361) | 1.99389500 |
180 | phospholipid dephosphorylation (GO:0046839) | 1.99316782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.72905953 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.11578690 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95652352 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.88758635 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85692165 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57483889 |
7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.48126990 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47544819 |
9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45338104 |
10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43362221 |
11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43362221 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41871604 |
13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40767022 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.40351175 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39252622 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36413856 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27448844 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26602224 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25471213 |
20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25377244 |
21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18285367 |
22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.14524925 |
23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.05038848 |
24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.03089415 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01536223 |
26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.00986495 |
27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00259881 |
28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99799189 |
29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97921626 |
30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93069192 |
31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93048343 |
32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92246845 |
33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92218377 |
34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.82613218 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79302789 |
36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77941997 |
37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77287117 |
38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76207188 |
39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75518758 |
40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74215153 |
41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71394121 |
42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66522625 |
43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.65714669 |
44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63915155 |
45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56240699 |
46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55861877 |
47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52388369 |
48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52337336 |
49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50375092 |
50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50035303 |
51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48091914 |
52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48072674 |
53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45619415 |
54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43912445 |
55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43696437 |
56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43023780 |
57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.40731721 |
58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40221166 |
59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39866079 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39175321 |
61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38738347 |
62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35115486 |
63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33779442 |
64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31088563 |
65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30016441 |
66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29839765 |
67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29150200 |
68 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28995205 |
69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28128990 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25600483 |
71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25567299 |
72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25202510 |
73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23539444 |
74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23404377 |
75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22835551 |
76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22028201 |
77 | * FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21802648 |
78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20473751 |
79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19087388 |
80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18382201 |
81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17937159 |
82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17838750 |
83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16788956 |
84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16570145 |
85 | AR_19668381_ChIP-Seq_PC3_Human | 1.16132183 |
86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15240222 |
87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15153160 |
88 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15042007 |
89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14535993 |
90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13754403 |
91 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13003238 |
92 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10315390 |
93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09416524 |
94 | * BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09278995 |
95 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09184782 |
96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08427977 |
97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08293049 |
98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06861079 |
99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06517502 |
100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06454820 |
101 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06222230 |
102 | JUN_21703547_ChIP-Seq_K562_Human | 1.05247511 |
103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04994524 |
104 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04604507 |
105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03025350 |
106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02837225 |
107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02332842 |
108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01258760 |
109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01151222 |
110 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00202146 |
111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99630264 |
112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99294646 |
113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97945635 |
114 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97649713 |
115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97551918 |
116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97523644 |
117 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97523644 |
118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97459356 |
119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97284413 |
120 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96502249 |
121 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96001712 |
122 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95730723 |
123 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95277651 |
124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95134203 |
125 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94565980 |
126 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94419373 |
127 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93675515 |
128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92507229 |
129 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92365040 |
130 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92047793 |
131 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91809447 |
132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91275894 |
133 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91188819 |
134 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90072355 |
135 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89545052 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89421275 |
137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89421275 |
138 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88948345 |
139 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88851844 |
140 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87775712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.17371868 |
2 | MP0003880_abnormal_central_pattern | 4.73583304 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.84744705 |
4 | MP0004270_analgesia | 3.31213094 |
5 | MP0009745_abnormal_behavioral_response | 3.29972723 |
6 | MP0009046_muscle_twitch | 3.15376805 |
7 | MP0002063_abnormal_learning/memory/cond | 3.08380042 |
8 | MP0002064_seizures | 3.07892966 |
9 | MP0001968_abnormal_touch/_nociception | 3.03074721 |
10 | MP0003195_calcinosis | 2.80488845 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.75493268 |
12 | MP0005423_abnormal_somatic_nervous | 2.64396059 |
13 | MP0002734_abnormal_mechanical_nocicepti | 2.58888820 |
14 | MP0002272_abnormal_nervous_system | 2.53376307 |
15 | MP0002735_abnormal_chemical_nociception | 2.46145928 |
16 | MP0003122_maternal_imprinting | 2.45992216 |
17 | MP0003724_increased_susceptibility_to | 2.40612438 |
18 | MP0002736_abnormal_nociception_after | 2.39634058 |
19 | MP0006276_abnormal_autonomic_nervous | 2.36956001 |
20 | MP0001486_abnormal_startle_reflex | 2.35711242 |
21 | MP0001501_abnormal_sleep_pattern | 2.34270837 |
22 | MP0005646_abnormal_pituitary_gland | 2.22155575 |
23 | MP0002822_catalepsy | 2.11936795 |
24 | MP0005645_abnormal_hypothalamus_physiol | 2.09856864 |
25 | MP0001440_abnormal_grooming_behavior | 2.08992111 |
26 | MP0002067_abnormal_sensory_capabilities | 2.06409495 |
27 | MP0001188_hyperpigmentation | 2.04130047 |
28 | MP0002733_abnormal_thermal_nociception | 2.03328419 |
29 | MP0003787_abnormal_imprinting | 2.01089096 |
30 | MP0001970_abnormal_pain_threshold | 1.94689406 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.94269603 |
32 | MP0002557_abnormal_social/conspecific_i | 1.84057993 |
33 | MP0004924_abnormal_behavior | 1.82759192 |
34 | MP0005386_behavior/neurological_phenoty | 1.82759192 |
35 | MP0002184_abnormal_innervation | 1.81822130 |
36 | MP0004510_myositis | 1.76716761 |
37 | MP0000778_abnormal_nervous_system | 1.76247455 |
38 | MP0008569_lethality_at_weaning | 1.73490404 |
39 | MP0002909_abnormal_adrenal_gland | 1.71176501 |
40 | MP0004811_abnormal_neuron_physiology | 1.67483498 |
41 | MP0001529_abnormal_vocalization | 1.66021409 |
42 | MP0004130_abnormal_muscle_cell | 1.63895880 |
43 | MP0001984_abnormal_olfaction | 1.63330618 |
44 | MP0004142_abnormal_muscle_tone | 1.50801957 |
45 | MP0000955_abnormal_spinal_cord | 1.48635718 |
46 | MP0003045_fibrosis | 1.44435322 |
47 | MP0002009_preneoplasia | 1.40141130 |
48 | MP0002971_abnormal_brown_adipose | 1.37519083 |
49 | MP0001905_abnormal_dopamine_level | 1.37283128 |
50 | MP0002882_abnormal_neuron_morphology | 1.34952783 |
51 | MP0004858_abnormal_nervous_system | 1.33195043 |
52 | MP0002066_abnormal_motor_capabilities/c | 1.32670839 |
53 | MP0001502_abnormal_circadian_rhythm | 1.32085177 |
54 | MP0002693_abnormal_pancreas_physiology | 1.30092714 |
55 | MP0004084_abnormal_cardiac_muscle | 1.29902440 |
56 | MP0004036_abnormal_muscle_relaxation | 1.28754955 |
57 | MP0003879_abnormal_hair_cell | 1.27531293 |
58 | MP0003300_gastrointestinal_ulcer | 1.23802257 |
59 | MP0002078_abnormal_glucose_homeostasis | 1.23603506 |
60 | MP0010386_abnormal_urinary_bladder | 1.23221177 |
61 | MP0003633_abnormal_nervous_system | 1.21760040 |
62 | MP0005075_abnormal_melanosome_morpholog | 1.20025293 |
63 | MP0005448_abnormal_energy_balance | 1.19313023 |
64 | MP0003303_peritoneal_inflammation | 1.19037813 |
65 | MP0003828_pulmonary_edema | 1.14915820 |
66 | MP0008961_abnormal_basal_metabolism | 1.14039759 |
67 | MP0002837_dystrophic_cardiac_calcinosis | 1.12998613 |
68 | MP0000631_abnormal_neuroendocrine_gland | 1.12562017 |
69 | MP0003121_genomic_imprinting | 1.12468674 |
70 | MP0003436_decreased_susceptibility_to | 1.12369129 |
71 | MP0000569_abnormal_digit_pigmentation | 1.11527851 |
72 | MP0001986_abnormal_taste_sensitivity | 1.10591928 |
73 | MP0003329_amyloid_beta_deposits | 1.06090745 |
74 | MP0002876_abnormal_thyroid_physiology | 1.06013897 |
75 | MP0000013_abnormal_adipose_tissue | 1.04609894 |
76 | MP0004885_abnormal_endolymph | 1.03625818 |
77 | MP0002152_abnormal_brain_morphology | 1.03366606 |
78 | MP0000751_myopathy | 1.01342509 |
79 | MP0008004_abnormal_stomach_pH | 1.01262830 |
80 | MP0005394_taste/olfaction_phenotype | 0.99545589 |
81 | MP0005499_abnormal_olfactory_system | 0.99545589 |
82 | MP0001944_abnormal_pancreas_morphology | 0.99400456 |
83 | MP0003631_nervous_system_phenotype | 0.98579612 |
84 | MP0005551_abnormal_eye_electrophysiolog | 0.98124285 |
85 | MP0003183_abnormal_peptide_metabolism | 0.98042123 |
86 | MP0002229_neurodegeneration | 0.97537810 |
87 | MP0005409_darkened_coat_color | 0.97437250 |
88 | MP0001835_abnormal_antigen_presentation | 0.96809751 |
89 | MP0002638_abnormal_pupillary_reflex | 0.96294595 |
90 | MP0004145_abnormal_muscle_electrophysio | 0.94768872 |
91 | MP0000604_amyloidosis | 0.94636531 |
92 | MP0005058_abnormal_lysosome_morphology | 0.94617324 |
93 | MP0002069_abnormal_eating/drinking_beha | 0.93667844 |
94 | MP0004883_abnormal_blood_vessel | 0.93535570 |
95 | MP0010329_abnormal_lipoprotein_level | 0.93485485 |
96 | MP0005535_abnormal_body_temperature | 0.92047886 |
97 | MP0002419_abnormal_innate_immunity | 0.91931644 |
98 | MP0005464_abnormal_platelet_physiology | 0.91891342 |
99 | MP0004085_abnormal_heartbeat | 0.91889973 |
100 | MP0006082_CNS_inflammation | 0.90986371 |
101 | MP0005171_absent_coat_pigmentation | 0.90518186 |
102 | MP0002332_abnormal_exercise_endurance | 0.90006711 |
103 | MP0002166_altered_tumor_susceptibility | 0.89250895 |
104 | MP0004742_abnormal_vestibular_system | 0.88690809 |
105 | MP0001765_abnormal_ion_homeostasis | 0.87333429 |
106 | MP0002127_abnormal_cardiovascular_syste | 0.86783000 |
107 | MP0005174_abnormal_tail_pigmentation | 0.86493045 |
108 | MP0003075_altered_response_to | 0.86329351 |
109 | MP0003953_abnormal_hormone_level | 0.86234306 |
110 | MP0009115_abnormal_fat_cell | 0.84031857 |
111 | MP0001963_abnormal_hearing_physiology | 0.83749734 |
112 | MP0005387_immune_system_phenotype | 0.81110800 |
113 | MP0001790_abnormal_immune_system | 0.81110800 |
114 | MP0001177_atelectasis | 0.79821082 |
115 | MP0006072_abnormal_retinal_apoptosis | 0.79347383 |
116 | MP0001348_abnormal_lacrimal_gland | 0.78687989 |
117 | MP0003634_abnormal_glial_cell | 0.78408810 |
118 | MP0008872_abnormal_physiological_respon | 0.78006645 |
119 | MP0001664_abnormal_digestion | 0.76589333 |
120 | MP0003656_abnormal_erythrocyte_physiolo | 0.74435101 |
121 | MP0002752_abnormal_somatic_nervous | 0.73975363 |
122 | MP0000015_abnormal_ear_pigmentation | 0.70594946 |
123 | MP0003123_paternal_imprinting | 0.69890519 |
124 | MP0004215_abnormal_myocardial_fiber | 0.69173465 |
125 | MP0002751_abnormal_autonomic_nervous | 0.68211973 |
126 | MP0003172_abnormal_lysosome_physiology | 0.67892810 |
127 | MP0004484_altered_response_of | 0.67756961 |
128 | MP0003690_abnormal_glial_cell | 0.67351324 |
129 | MP0008874_decreased_physiological_sensi | 0.67179953 |
130 | MP0001943_abnormal_respiration | 0.66102960 |
131 | MP0005379_endocrine/exocrine_gland_phen | 0.64923278 |
132 | MP0008877_abnormal_DNA_methylation | 0.64185114 |
133 | MP0003632_abnormal_nervous_system | 0.62635551 |
134 | MP0003283_abnormal_digestive_organ | 0.62012780 |
135 | MP0001299_abnormal_eye_distance/ | 0.60771257 |
136 | MP0005187_abnormal_penis_morphology | 0.57598912 |
137 | MP0005253_abnormal_eye_physiology | 0.56697552 |
138 | MP0004043_abnormal_pH_regulation | 0.56600209 |
139 | MP0003137_abnormal_impulse_conducting | 0.55433035 |
140 | MP0000920_abnormal_myelination | 0.55251051 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.62807641 |
2 | Focal seizures (HP:0007359) | 5.35827560 |
3 | Atonic seizures (HP:0010819) | 5.05689302 |
4 | Visual hallucinations (HP:0002367) | 4.94305212 |
5 | Myokymia (HP:0002411) | 4.90730714 |
6 | Febrile seizures (HP:0002373) | 4.87443655 |
7 | Epileptic encephalopathy (HP:0200134) | 4.63478135 |
8 | Absence seizures (HP:0002121) | 4.35238262 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.06767136 |
10 | Dialeptic seizures (HP:0011146) | 4.01758747 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 3.89161033 |
12 | Broad-based gait (HP:0002136) | 3.38684753 |
13 | Hyperventilation (HP:0002883) | 3.31407519 |
14 | Papilledema (HP:0001085) | 3.31165289 |
15 | Bundle branch block (HP:0011710) | 3.30342268 |
16 | Episodic fever (HP:0001954) | 3.23908487 |
17 | Increased circulating renin level (HP:0000848) | 3.14895923 |
18 | Truncal ataxia (HP:0002078) | 3.09673272 |
19 | Pheochromocytoma (HP:0002666) | 3.06271937 |
20 | Abnormal eating behavior (HP:0100738) | 3.06083475 |
21 | Action tremor (HP:0002345) | 3.04912390 |
22 | Ventricular fibrillation (HP:0001663) | 3.04287686 |
23 | Progressive inability to walk (HP:0002505) | 3.00543537 |
24 | Gaze-evoked nystagmus (HP:0000640) | 2.95811685 |
25 | Anxiety (HP:0000739) | 2.93761461 |
26 | Ankle clonus (HP:0011448) | 2.89438436 |
27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.89069650 |
28 | Depression (HP:0000716) | 2.88348334 |
29 | Drooling (HP:0002307) | 2.84387292 |
30 | Excessive salivation (HP:0003781) | 2.84387292 |
31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.77501229 |
32 | Agitation (HP:0000713) | 2.75054354 |
33 | Poor eye contact (HP:0000817) | 2.73805599 |
34 | Polyphagia (HP:0002591) | 2.71389583 |
35 | Absent speech (HP:0001344) | 2.67661384 |
36 | Neuroendocrine neoplasm (HP:0100634) | 2.67312872 |
37 | Testicular neoplasm (HP:0010788) | 2.66808976 |
38 | Abnormal hair whorl (HP:0010721) | 2.66659302 |
39 | Gait imbalance (HP:0002141) | 2.65305222 |
40 | Dysdiadochokinesis (HP:0002075) | 2.65009849 |
41 | Failure to thrive in infancy (HP:0001531) | 2.64143332 |
42 | Limb dystonia (HP:0002451) | 2.63277427 |
43 | Amblyopia (HP:0000646) | 2.62394720 |
44 | Asymmetric septal hypertrophy (HP:0001670) | 2.60940311 |
45 | Supranuclear gaze palsy (HP:0000605) | 2.57930982 |
46 | Mutism (HP:0002300) | 2.57722887 |
47 | Scanning speech (HP:0002168) | 2.56063861 |
48 | Inability to walk (HP:0002540) | 2.53645598 |
49 | Epileptiform EEG discharges (HP:0011182) | 2.52231709 |
50 | Syncope (HP:0001279) | 2.51684630 |
51 | Hyperglycemia (HP:0003074) | 2.47108328 |
52 | Postural instability (HP:0002172) | 2.46185023 |
53 | Abnormal social behavior (HP:0012433) | 2.45885305 |
54 | Impaired social interactions (HP:0000735) | 2.45885305 |
55 | Ketoacidosis (HP:0001993) | 2.43797002 |
56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.40454520 |
57 | Hypoglycemic seizures (HP:0002173) | 2.40277072 |
58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38430075 |
59 | Mucopolysacchariduria (HP:0008155) | 2.38430075 |
60 | Impaired smooth pursuit (HP:0007772) | 2.38178697 |
61 | Dysmetria (HP:0001310) | 2.36910071 |
62 | Stomatitis (HP:0010280) | 2.35470199 |
63 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.33727144 |
64 | Protruding tongue (HP:0010808) | 2.33627525 |
65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32870928 |
66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32870928 |
67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32870928 |
68 | Increased CSF protein (HP:0002922) | 2.32450667 |
69 | Insidious onset (HP:0003587) | 2.32380499 |
70 | Termporal pattern (HP:0011008) | 2.32380499 |
71 | Congenital primary aphakia (HP:0007707) | 2.31458391 |
72 | Eczematoid dermatitis (HP:0000976) | 2.31435830 |
73 | Fetal akinesia sequence (HP:0001989) | 2.30805198 |
74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.30753339 |
75 | Blue irides (HP:0000635) | 2.29814950 |
76 | Dysostosis multiplex (HP:0000943) | 2.28530718 |
77 | Bradykinesia (HP:0002067) | 2.28456698 |
78 | Genetic anticipation (HP:0003743) | 2.27522165 |
79 | Sudden death (HP:0001699) | 2.26596032 |
80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.26511045 |
81 | Gastrointestinal infarctions (HP:0005244) | 2.26430949 |
82 | Gingival bleeding (HP:0000225) | 2.26119860 |
83 | Hypsarrhythmia (HP:0002521) | 2.25372913 |
84 | Medial flaring of the eyebrow (HP:0010747) | 2.23474384 |
85 | Urinary urgency (HP:0000012) | 2.20393830 |
86 | Abnormality of the corticospinal tract (HP:0002492) | 2.20209325 |
87 | Macroorchidism (HP:0000053) | 2.19270260 |
88 | Spastic gait (HP:0002064) | 2.18919786 |
89 | Hypoventilation (HP:0002791) | 2.18827442 |
90 | Abnormality of binocular vision (HP:0011514) | 2.18539206 |
91 | Diplopia (HP:0000651) | 2.18539206 |
92 | Hemiparesis (HP:0001269) | 2.17529301 |
93 | Ventricular arrhythmia (HP:0004308) | 2.17416139 |
94 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17414032 |
95 | Amyloidosis (HP:0011034) | 2.17353726 |
96 | Recurrent bacterial skin infections (HP:0005406) | 2.15258185 |
97 | Retrobulbar optic neuritis (HP:0100654) | 2.15241129 |
98 | Optic neuritis (HP:0100653) | 2.15241129 |
99 | Abnormality of macrophages (HP:0004311) | 2.12901107 |
100 | Specific learning disability (HP:0001328) | 2.12389071 |
101 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.11965140 |
102 | Myositis (HP:0100614) | 2.11377076 |
103 | Hypothermia (HP:0002045) | 2.10881691 |
104 | Retinal dysplasia (HP:0007973) | 2.09713604 |
105 | Orchitis (HP:0100796) | 2.08864726 |
106 | Intention tremor (HP:0002080) | 2.01998561 |
107 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.01075539 |
108 | Lower limb muscle weakness (HP:0007340) | 2.00830468 |
109 | Heart block (HP:0012722) | 2.00690174 |
110 | Neurofibrillary tangles (HP:0002185) | 1.99387703 |
111 | Prolonged bleeding time (HP:0003010) | 1.99375070 |
112 | Papillary thyroid carcinoma (HP:0002895) | 1.97036431 |
113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96691507 |
114 | Recurrent abscess formation (HP:0002722) | 1.96682414 |
115 | Large for gestational age (HP:0001520) | 1.95765873 |
116 | Spontaneous hematomas (HP:0007420) | 1.94908505 |
117 | Obstructive sleep apnea (HP:0002870) | 1.94333211 |
118 | Hyperthyroidism (HP:0000836) | 1.91931099 |
119 | Poor suck (HP:0002033) | 1.91764269 |
120 | Generalized hypopigmentation of hair (HP:0011358) | 1.91759399 |
121 | Hypoglycemic coma (HP:0001325) | 1.91757370 |
122 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91368621 |
123 | Hypoplasia of the brainstem (HP:0002365) | 1.91310913 |
124 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.91310913 |
125 | Stereotypic behavior (HP:0000733) | 1.91288705 |
126 | Hypomagnesemia (HP:0002917) | 1.90523764 |
127 | Arthropathy (HP:0003040) | 1.90393979 |
128 | Psychosis (HP:0000709) | 1.90316278 |
129 | Genital tract atresia (HP:0001827) | 1.89388408 |
130 | Enlarged penis (HP:0000040) | 1.89163830 |
131 | Menstrual irregularities (HP:0000858) | 1.88427452 |
132 | Bradycardia (HP:0001662) | 1.88276516 |
133 | Abnormality of salivation (HP:0100755) | 1.87353469 |
134 | Mitral stenosis (HP:0001718) | 1.86839581 |
135 | Abnormal drinking behavior (HP:0030082) | 1.86650402 |
136 | Polydipsia (HP:0001959) | 1.86650402 |
137 | Hyperphosphatemia (HP:0002905) | 1.85850267 |
138 | Global brain atrophy (HP:0002283) | 1.85230634 |
139 | Generalized myoclonic seizures (HP:0002123) | 1.85196312 |
140 | Vaginal atresia (HP:0000148) | 1.85175881 |
141 | Esotropia (HP:0000565) | 1.85156326 |
142 | Progressive neurologic deterioration (HP:0002344) | 1.85134319 |
143 | Impaired vibratory sensation (HP:0002495) | 1.84703841 |
144 | Open mouth (HP:0000194) | 1.84397141 |
145 | Hematochezia (HP:0002573) | 1.84225689 |
146 | Growth hormone excess (HP:0000845) | 1.83424534 |
147 | Abnormal EKG (HP:0003115) | 1.82632546 |
148 | Hyperlipoproteinemia (HP:0010980) | 1.82577664 |
149 | Dysmetric saccades (HP:0000641) | 1.82407715 |
150 | Frequent falls (HP:0002359) | 1.81958947 |
151 | Exotropia (HP:0000577) | 1.81646864 |
152 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.81428882 |
153 | Absent/shortened dynein arms (HP:0200106) | 1.81428882 |
154 | Striae distensae (HP:0001065) | 1.81013373 |
155 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.80871982 |
156 | Type II lissencephaly (HP:0007260) | 1.80513818 |
157 | EMG: myopathic abnormalities (HP:0003458) | 1.79948170 |
158 | Akinesia (HP:0002304) | 1.79857537 |
159 | Hyporeflexia of lower limbs (HP:0002600) | 1.79724512 |
160 | Hemiplegia (HP:0002301) | 1.79208435 |
161 | Atrioventricular block (HP:0001678) | 1.78669944 |
162 | Gait ataxia (HP:0002066) | 1.78485735 |
163 | Oligomenorrhea (HP:0000876) | 1.76672099 |
164 | Torticollis (HP:0000473) | 1.76134382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.46246282 |
2 | CASK | 3.83050260 |
3 | MARK1 | 3.27204149 |
4 | MAP3K4 | 3.13614785 |
5 | MAP2K7 | 3.03616568 |
6 | MAP3K9 | 2.94072770 |
7 | MAP3K12 | 2.86162567 |
8 | EPHA4 | 2.77854849 |
9 | MINK1 | 2.65609236 |
10 | TRIM28 | 2.51178079 |
11 | NTRK2 | 2.17696007 |
12 | MAP2K4 | 2.02899110 |
13 | TNIK | 1.86323193 |
14 | MAPK13 | 1.83997129 |
15 | PNCK | 1.80113581 |
16 | TAOK1 | 1.79440732 |
17 | PLK2 | 1.72520269 |
18 | DAPK2 | 1.61953216 |
19 | PRPF4B | 1.53033511 |
20 | PAK6 | 1.51518027 |
21 | SGK2 | 1.45687592 |
22 | FES | 1.43530714 |
23 | AKT3 | 1.42535656 |
24 | NTRK1 | 1.41317400 |
25 | CDK5 | 1.39748987 |
26 | KSR1 | 1.39059365 |
27 | GRK5 | 1.38440471 |
28 | UHMK1 | 1.35653779 |
29 | PRKD3 | 1.32844079 |
30 | RIPK4 | 1.31245716 |
31 | SGK223 | 1.29665503 |
32 | SGK494 | 1.29665503 |
33 | CAMKK2 | 1.26597862 |
34 | PRKCG | 1.23644729 |
35 | CAMKK1 | 1.21085007 |
36 | ARAF | 1.20882330 |
37 | TRPM7 | 1.20556602 |
38 | DAPK1 | 1.20461340 |
39 | CDK19 | 1.19770287 |
40 | OBSCN | 1.15384128 |
41 | SIK2 | 1.14189279 |
42 | EPHB1 | 1.13926510 |
43 | EPHA3 | 1.13792501 |
44 | KSR2 | 1.12025761 |
45 | SIK3 | 1.11802462 |
46 | HIPK2 | 1.10288838 |
47 | CAMK2A | 1.09814245 |
48 | PIK3CG | 1.09307998 |
49 | JAK1 | 1.07177007 |
50 | YES1 | 1.02518782 |
51 | GRK6 | 1.01684332 |
52 | FGFR3 | 1.00697223 |
53 | SGK3 | 0.99819750 |
54 | WNK3 | 0.98281615 |
55 | CSNK1G2 | 0.97816753 |
56 | TYK2 | 0.94398041 |
57 | GRK7 | 0.93858804 |
58 | CSK | 0.88431704 |
59 | MAP2K6 | 0.88345018 |
60 | IRAK4 | 0.88320859 |
61 | PRKCH | 0.87615351 |
62 | JAK2 | 0.86435230 |
63 | MAP3K2 | 0.86301178 |
64 | TNK2 | 0.84718522 |
65 | SYK | 0.83832312 |
66 | ERBB3 | 0.83716798 |
67 | ZAP70 | 0.82935279 |
68 | TAOK3 | 0.80940241 |
69 | BLK | 0.80222152 |
70 | CAMK2B | 0.79618298 |
71 | PAK3 | 0.79557239 |
72 | PRKD2 | 0.78223323 |
73 | BMPR2 | 0.77989761 |
74 | CAMK1G | 0.77325134 |
75 | MAP2K3 | 0.77280279 |
76 | CAMK1 | 0.76559296 |
77 | PRKCE | 0.76045614 |
78 | PHKG2 | 0.75730762 |
79 | PHKG1 | 0.75730762 |
80 | STK38 | 0.74904829 |
81 | PDPK1 | 0.74837256 |
82 | SGK1 | 0.74798961 |
83 | OXSR1 | 0.73949074 |
84 | IKBKE | 0.73371278 |
85 | RPS6KA2 | 0.71219025 |
86 | NLK | 0.71187558 |
87 | CCNB1 | 0.70370715 |
88 | MAPK12 | 0.69838634 |
89 | CDK18 | 0.67859077 |
90 | CDK14 | 0.65303781 |
91 | MAP3K7 | 0.65130184 |
92 | STK11 | 0.64550524 |
93 | PINK1 | 0.62791234 |
94 | DYRK1A | 0.61883105 |
95 | INSRR | 0.61772980 |
96 | WNK1 | 0.61731537 |
97 | BCR | 0.60894645 |
98 | ACVR1B | 0.60407770 |
99 | RET | 0.60188087 |
100 | CDK15 | 0.60051749 |
101 | FER | 0.59991175 |
102 | CSNK1G3 | 0.58957883 |
103 | CAMK2D | 0.57024744 |
104 | HCK | 0.56531168 |
105 | LYN | 0.55443897 |
106 | IRAK2 | 0.55396978 |
107 | FGFR2 | 0.53966567 |
108 | BRAF | 0.53285266 |
109 | MAP3K1 | 0.53215041 |
110 | NEK6 | 0.53107068 |
111 | ITK | 0.53052527 |
112 | PTK2B | 0.52927921 |
113 | CAMK2G | 0.52757544 |
114 | PRKAA1 | 0.51262766 |
115 | MAP3K13 | 0.50074241 |
116 | CDC42BPA | 0.49866768 |
117 | CDK11A | 0.49427208 |
118 | ADRBK2 | 0.49135109 |
119 | CSF1R | 0.48967955 |
120 | ADRBK1 | 0.47554156 |
121 | FRK | 0.46279337 |
122 | RPS6KA3 | 0.46096148 |
123 | MAP3K6 | 0.46078459 |
124 | IRAK1 | 0.45636971 |
125 | PRKG1 | 0.45470087 |
126 | PRKAA2 | 0.44690932 |
127 | TXK | 0.44446305 |
128 | MARK2 | 0.44072898 |
129 | TTN | 0.44002275 |
130 | RPS6KB1 | 0.42689672 |
131 | MAP4K1 | 0.42406045 |
132 | MOS | 0.41953372 |
133 | RAF1 | 0.41777141 |
134 | CSNK1A1L | 0.41103108 |
135 | MAPK10 | 0.40315940 |
136 | PRKCZ | 0.39822496 |
137 | CAMK4 | 0.39196583 |
138 | PRKACA | 0.38355638 |
139 | PRKCB | 0.37742918 |
140 | PDK1 | 0.34715557 |
141 | NME1 | 0.34591490 |
142 | MUSK | 0.34468932 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.13535239 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.37456954 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80449870 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75427982 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63511223 |
6 | Morphine addiction_Homo sapiens_hsa05032 | 2.59312804 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.56544357 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.47125952 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42854633 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39737544 |
11 | Insulin secretion_Homo sapiens_hsa04911 | 2.20681179 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.18245479 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.16250870 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98567370 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.97684963 |
16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.94701051 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.93034851 |
18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91045858 |
19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.86078331 |
20 | Long-term depression_Homo sapiens_hsa04730 | 1.79901314 |
21 | Renin secretion_Homo sapiens_hsa04924 | 1.79195669 |
22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78206368 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66713765 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.65087315 |
25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62799804 |
26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52808503 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50139824 |
28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47951775 |
29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.42341328 |
30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36187739 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35925265 |
32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.30967376 |
33 | Gap junction_Homo sapiens_hsa04540 | 1.29607722 |
34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29464003 |
35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23149571 |
36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20947583 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19441466 |
38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18126587 |
39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11201286 |
40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09372982 |
41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09213238 |
42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06110924 |
43 | Phototransduction_Homo sapiens_hsa04744 | 1.05523820 |
44 | Axon guidance_Homo sapiens_hsa04360 | 1.04506563 |
45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04473972 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03506717 |
47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02012279 |
48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01709913 |
49 | Platelet activation_Homo sapiens_hsa04611 | 1.00172358 |
50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98582771 |
51 | Insulin resistance_Homo sapiens_hsa04931 | 0.97712549 |
52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95447522 |
53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93610433 |
54 | Melanogenesis_Homo sapiens_hsa04916 | 0.92930378 |
55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91659955 |
56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90015512 |
57 | Glioma_Homo sapiens_hsa05214 | 0.89398433 |
58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88678928 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87188963 |
60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85162339 |
61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82548237 |
62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81745074 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81585785 |
64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81494940 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81307272 |
66 | ABC transporters_Homo sapiens_hsa02010 | 0.79411473 |
67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79262629 |
68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78554430 |
69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77903754 |
70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77453620 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76691455 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75967002 |
73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75266458 |
74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75183434 |
75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74671339 |
76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74468201 |
77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70879915 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69529070 |
79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69060203 |
80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68351778 |
81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67619118 |
82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66819299 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66285383 |
84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64791036 |
85 | Tuberculosis_Homo sapiens_hsa05152 | 0.63605041 |
86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63263420 |
87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61844502 |
88 | Lysosome_Homo sapiens_hsa04142 | 0.61244365 |
89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61093936 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60928420 |
91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59779078 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58970684 |
93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.58492137 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57625138 |
95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57141694 |
96 | Alcoholism_Homo sapiens_hsa05034 | 0.57084830 |
97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56788586 |
98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55149466 |
99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54341755 |
100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54090175 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53610994 |
102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52417611 |
103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52110746 |
104 | Bile secretion_Homo sapiens_hsa04976 | 0.51788191 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51146116 |
106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50392486 |
107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50143991 |
108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49649485 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47519801 |
110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44374642 |
111 | Phagosome_Homo sapiens_hsa04145 | 0.43263197 |
112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43074517 |
113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41753695 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41627396 |
115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41619083 |
116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41215175 |
117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40221378 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39773629 |
119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39462123 |
120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39224596 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38944286 |
122 | Prion diseases_Homo sapiens_hsa05020 | 0.37899422 |
123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34229029 |
124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33861682 |
125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33407256 |
126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32072691 |
127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31290770 |
128 | Endocytosis_Homo sapiens_hsa04144 | 0.30693658 |
129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30242885 |
130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28512604 |
131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24364202 |
132 | Melanoma_Homo sapiens_hsa05218 | 0.23463118 |